RecruitingNCT05497024

Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing


Sponsor

M.D. Anderson Cancer Center

Enrollment

45 participants

Start Date

Aug 15, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

This protocol describes development and user testing of an educational shared decision making intervention to help men with prostate cancer who are on active surveillance make decisions with their health care providers about if and when to de-escalate surveillance testing. The project is important because for many patients their cancer does not progress to the point of needed curative treatment or their health status changes such that they are no longer good candidates for treatment. For these men, de-escalating ongoing surveillance (e.g., fewer biopsies or imaging studies) is a reasonable option.


Eligibility

Sex: MALEMin Age: 65 Years

Inclusion Criteria11

  • Patients
  • Males aged 65 or older
  • Diagnosis of localized prostate cancer
  • On active surveillance for 12 or more months
  • Fluent in English
  • Aged 18 or older
  • Fluent in English
  • Involved with the care of an eligible patient (i.e. partner, close friend, family member, companion)
  • Aged 18 or older
  • Fluent in English
  • Provides clinical care for patients with prostate cancer (e.g. medical oncologists, urologists, radiation oncologists, nurse practitioners, physician assistants)

Exclusion Criteria5

  • \. Receiving treatment for another cancer (primary or recurrence)
  • Caregivers
  • None
  • Clinicians
  • \. None

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALInterviews

Participants will discuss background, such as race, education, and living situation. Participants will discuss Prostate cancer Participants will discuss feedback on the educational material

BEHAVIORALSurveys

Participants may answer questions that are sensitive in nature.


Locations(1)

M D Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05497024


Related Trials